Netherlands· NL-b32814c79e7c

Megestrolacetaat 160 mg Focus, tabletten

A megestrol product containing megestrolacetaat, registered in Netherlands by Focus Care Pharmaceuticals B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC L02AB01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about megestrolacetaatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Megestrol is registered in 11 of 19 countries.

Countries holding a registration under ATC L02AB01 (megestrol), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search megestrol products by name

Megestrol · ATC L02AB01

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of megestrol costs, country by country.

Normalised to the WHO defined daily dose (0.16 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Megestrol · price per daily dose (0.16 g)

USD · FX 28 Sept 2026

IT Italy$2.30

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: MEGESTROLACETAAT
Manufacturer: Focus Care Pharmaceuticals B.V.
Country: Netherlands (NL)
ATC code: L02AB01
ATC class: Megestrol
Defined daily dose: 0.16 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
122993

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

152 interactions on record for megestrol.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check megestrol against other medicines How interaction checks work

Megestrol · interactions on record

152 records

2 severe
147 moderate
3 minor

Most severe, free to view

DofetilideC01BD04severe
ThalidomideL04AX02severe
AprepitantA04AD12moderate
LiraglutidA08AX02moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Megestrol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All megestrol products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

Belgium · Megace
Cyprus · Megace
Czechia · Megace, Megaplex
Germany · Megestat
Spain · Borea, Maygace Altas Dosis
France · Megace
United Kingdom (Northern Ireland) · Megace
Greece · Megace
Croatia · Megace, Megostat
Hungary · Cachexi, Megace
Ireland · Megace
Italy · Gestroltex, Megace
Lithuania · Megace
Luxembourg · Megace
Norway · Megace
Poland · Cachexan, Megace
Portugal · Megace, Megestrol Generis
Romania · Megesin
Sweden · Megace
Slovenia · Megace
Slovakia · Megesin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/60b70558-46e6-46a9-9ad8-a7bb50e4e90d
GET /v1/drugs/60b70558-46e6-46a9-9ad8-a7bb50e4e90d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h122993_smpc.pdf",
  "strength": null,
  "atc_label": "Megestrol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg122993",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "POVIDON K 30 (E 1201)",
    "SILICIUMDIOXIDE (E 551)"
  ],
  "substances": [
    "MEGESTROLACETAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h122993.pdf",
  "authorised_at": "2020/09/11",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "122993",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about megestrol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console